|
Delaware
|
| |
6770
|
| |
86-2556699
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer
Identification No.) |
|
|
Jerry Hyman
Chairman 400 Skokie Blvd Suite 820 Northbrook, Illinois 60062 (847) 757-3812 |
| |
Keith Jaffee
Chief Executive Officer 400 Skokie Blvd Suite 820 Northbrook, Illinois 60062 (847) 757-3812 |
|
|
Mark D. Wood
Brian Hecht Evan S. Borenstein Katten Muchin Rosenman LLP 575 Madison Avenue New York, New York 10022 Tel: (212) 940-8800 |
| |
Stuart Neuhauser
Ellenoff Grossman & Schole LLP 1345 Avenue of the Americas New York, New York 10105 Telephone: (212) 370-1300 |
|
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☒ | | |
Smaller reporting company ☒
Emerging growth company ☒ |
|
| | |||||||||||||||||||||||||
Title of Each Class of Security Being Registered
|
| | |
Amount
to be Registered |
| | |
Proposed
Maximum Offering Price Per Unit(1) |
| | |
Proposed
Maximum Aggregate Offering Price(1)(2) |
| | |
Amount of
Registration Fee |
| |||||||||
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-third of one redeemable warrant(2)
|
| | |
34,500,000 units
|
| | | | $ | 10.00 | | | | | | $ | 345,000,000 | | | | | | $ | 37,639.50 | | |
Shares of Class A common stock included as part of the units(3)
|
| | |
34,500,000 shares
|
| | | | | — | | | | | | | — | | | | | | | —(4) | | |
Redeemable warrants included as part of the units(3)
|
| | |
11,500,000 warrants
|
| | | | | — | | | | | | | — | | | | | | | —(4) | | |
Total
|
| | | | | | | | | — | | | | | | $ | 345,000,000 | | | | | | $ | 37,639.50 | | |
| | | | | 1 | | | |
| | | | | 10 | | | |
| | | | | 35 | | | |
| | | | | 36 | | | |
| | | | | 74 | | | |
| | | | | 79 | | | |
| | | | | 80 | | | |
| | | | | 82 | | | |
| | | | | 84 | | | |
| | | | | 90 | | | |
| | | | | 122 | | | |
| | | | | 131 | | | |
| | | | | 134 | | | |
| | | | | 137 | | | |
| | | | | 155 | | | |
| | | | | 165 | | | |
| | | | | 172 | | | |
| | | | | 172 | | | |
| | | | | 172 | | | |
| | | | | F-1 | | |
| | |
March 31, 2021
|
| |||||||||
Balance Sheet Data:
|
| |
Actual
|
| |
As Adjusted
|
| ||||||
Working capital (deficiency)
|
| | | $ | (203,448) | | | | | $ | 274,984,548 | | |
Total assets
|
| | | $ | 222,995 | | | | | $ | 300,994,548 | | |
Total liabilities
|
| | | $ | 228,448 | | | | | $ | 26,010,000 | | |
Value of Class A common stock subject to possible redemption
|
| | | $ | — | | | | | $ | 269,984,547 | | |
Stockholders’ equity
|
| | | $ | (5,453) | | | | | $ | 5,000,001 | | |
|
Public shares
|
| | | | 30,000,000 | | |
|
Founder shares
|
| | | | 7,500,000 | | |
|
Total shares
|
| | | | 37,500,000 | | |
|
Total funds in trust available for initial business combination
|
| | | $ | 300,000,000 | | |
|
Initial implied value per public share
|
| | | $ | 10.00 | | |
|
Implied value per share upon consummation of initial business combination
|
| | | $ | 8.00 | | |
| | |
Without
Over-allotment Option |
| |
Over-allotment
Option Exercised |
| ||||||
Gross proceeds | | | | | | | | | | | | | |
Gross proceeds from units offered to public(1)
|
| | | $ | 300,000,000 | | | | | $ | 345,000,000 | | |
Gross proceeds from private placement warrants offered in the private placement
|
| | | | 8,125,000 | | | | | | 9,025,000 | | |
Total gross proceeds
|
| | | $ | 308,125,000 | | | | | $ | 354,025,000 | | |
Estimated offering expenses(2) | | | | | | | | | | | | | |
Underwriting commissions (2.0% of gross proceeds from units offered to public, excluding deferred portion)(3)
|
| | | $ | 6,000,000 | | | | | $ | 6,900,000 | | |
Legal fees and expenses
|
| | | | 250,000 | | | | | | 250,000 | | |
Printing and engraving expenses
|
| | | | 40,000 | | | | | | 40,000 | | |
Accounting fees and expenses
|
| | | | 45,000 | | | | | | 45,000 | | |
SEC/FINRA Expenses
|
| | | | 89,890 | | | | | | 89,950 | | |
Travel and road show
|
| | | | 20,000 | | | | | | 20,000 | | |
NYSE listing and filing fees
|
| | | | 85,000 | | | | | | 85,000 | | |
Director & Officer liability insurance premiums(4)
|
| | | | 350,000 | | | | | | 350,000 | | |
Miscellaneous(5) | | | | | 245,110 | | | | | | 245,110 | | |
Total estimated offering expenses (excluding underwriting commissions)
|
| | | $ | 1,125,000 | | | | | $ | 1,125,000 | | |
Proceeds after estimated offering expenses
|
| | | $ | 301,000,000 | | | | | $ | 346,000,000 | | |
Held in trust account(3)
|
| | | $ | 300,000,000 | | | | | $ | 345,000,000 | | |
% of public offering size
|
| | | | 100% | | | | | | 100% | | |
Not held in trust account
|
| | | $ | 1,000,000 | | | | | $ | 1,000,000 | | |
| | |
Amount
|
| |
% of Total
|
| ||||||
Legal, accounting, due diligence, travel, and other expenses in connection with any business combination(7)
|
| | | $ | 400,000 | | | | | | 40.0% | | |
Legal and accounting fees related to regulatory reporting obligations
|
| | | | 160,000 | | | | | | 16.0% | | |
Payment for office space, administrative and support services(8)
|
| | | | 240,000 | | | | | | 24.0% | | |
NYSE continued listing fees
|
| | | | 165,000 | | | | | | 16.5% | | |
Working capital to cover miscellaneous expenses and reserves
|
| | | | 35,000 | | | | | | 3.5% | | |
Total
|
| | | $ | 1,000,000 | | | | | | 100.0% | | |
| | |
Without
Over-allotment |
| |
With
Over-allotment |
| ||||||
Public offering price
|
| | | $ | 10.00 | | | | | $ | 10.00 | | |
Net tangible book deficit before this offering
|
| | | | (0.03) | | | | | | (0.02) | | |
Increase attributable to public stockholders
|
| | | | 0.51 | | | | | | 0.44 | | |
Pro forma net tangible book value after this offering and the sale of the private placement warrants
|
| | | | 0.48 | | | | | | 0.42 | | |
Dilution to public stockholders
|
| | | $ | 9.52 | | | | | $ | 9.58 | | |
Percentage of dilution to public stockholders
|
| | | | 95.2% | | | | | | 95.8% | | |
| | |
Shares Purchased
|
| |
Total Consideration
|
| |
Average
Price per share |
| |||||||||||||||||||||
| | |
Number
|
| |
Percentage
|
| |
Amount
|
| |
Percentage
|
| ||||||||||||||||||
Class B common stock(1)
|
| | | | 7,500,000 | | | | | | 20.0% | | | | | $ | 25,000 | | | | | | 0.01% | | | | | $ | 0.003 | | |
Public Stockholders
|
| | | | 30,000,000 | | | | | | 80.0% | | | | | $ | 300,000,000 | | | | | | 99.99% | | | | | $ | 10.00 | | |
| | | | | 37,500,000 | | | | | | 100.0% | | | | | $ | 300,025,000 | | | | | | 100.0% | | | | | | | | |
| | |
Without
Over-allotment |
| |
With
Over-allotment |
| ||||||
Numerator: | | | | | | | | | | | | | |
Net tangible book deficit before this offering
|
| | | $ | (203,448) | | | | | $ | (203,448) | | |
Net proceeds from this offering and sale of the private placement
warrants |
| | | | 301,000,000 | | | | | | 346,000,000 | | |
Plus: Offering costs accrued or paid in advance, excluded from tangible book value before this offering
|
| | | | 197,994 | | | | | | 197,994 | | |
Less: Warrant Liability(1)
|
| | | | (15,510,000) | | | | | | (17,619,000) | | |
Less: Deferred underwriting commissions
|
| | | | (10,500,000) | | | | | | (12,075,000) | | |
Less: Assumed maximum proceeds available for a redemption to effect a business combination
|
| | | | 269,984,545 | | | | | | (311.300.545) | | |
| | | | $ | 5,000,001 | | | | | $ | 5,000,001 | | |
Denominator: | | | | | | | | | | | | | |
Common stock outstanding prior to this offering
|
| | | | 8,625,000 | | | | | | 8,625,000 | | |
Common stock forfeited if over-allotment is not exercised
|
| | | | (1,125,000) | | | | | | — | | |
Common stock included in the units offered
|
| | | | 30,000,000 | | | | | | 34,500,000 | | |
Less: Maximum shares that may be redeemed to effect a business
combination |
| | | | (26,998,454) | | | | | | (31,130,054) | | |
| | | | | 10,501,546 | | | | | | 11,994,946 | | |
| | |
March 31, 2021
|
| |||||||||
| | |
Actual
|
| |
As Adjusted(2)
|
| ||||||
Promissory note – related party(1)
|
| | | $ | — | | | | | $ | — | | |
Deferred underwriting commissions
|
| | | | — | | | | | | 10,500,000 | | |
Warrant Liability(3)
|
| | | | — | | | | | | 15,510,000 | | |
Class A common stock, $0.0001 par value, 240,000,000 shares authorized: -0- and 26,998,454 shares are subject to possible redemption(4)(5)
|
| | | | — | | | | | | 269,984,545 | | |
-0- and 3,001,546 shares, as adjusted
|
| | | | — | | | | | | 300 | | |
Preferred stock, $0.0001 par value, 1,000,000 shares authorized, actual and as adjusted; none issued or outstanding, actual and as adjusted
|
| | | | — | | | | | | — | | |
Class B common stock, $0.0001 par value, 60,000,000 shares authorized, actual and as adjusted; 8,625,000 and 7,500,000 shares issued and outstanding, actual and as adjusted, respectively
|
| | | | 863 | | | | | | 750 | | |
Additional paid-in capital(6)
|
| | | | 24,137 | | | | | | 5,614,437 | | |
Accumulated deficit(7)
|
| | | | (30,453) | | | | | | (615,486) | | |
Total stockholders’ equity
|
| | | $ | (5,453) | | | | | $ | 5,000,001 | | |
Total capitalization
|
| | | $ | (5,453) | | | | | $ | 300,994,546 | | |
Type of Transaction
|
| |
Whether Stockholder
Approval is Required |
|
Purchase of assets | | | No | |
Purchase of stock of target not involving a merger with the company | | | No | |
Merger of target with a subsidiary of the company | | | No | |
Merger of the company with a target | | | Yes | |